3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      An Integrative Multi-Omics Workflow to Address Multifactorial Toxicology Experiments

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Toxicology studies can take advantage of omics approaches to better understand the phenomena underlying the phenotypic alterations induced by different types of exposure to certain toxicants. Nevertheless, in order to analyse the data generated from multifactorial omics studies, dedicated data analysis tools are needed. In this work, we propose a new workflow comprising both factor deconvolution and data integration from multiple analytical platforms. As a case study, 3D neural cell cultures were exposed to trimethyltin (TMT) and the relevance of the culture maturation state, the exposure duration, as well as the TMT concentration were simultaneously studied using a metabolomic approach combining four complementary analytical techniques (reversed-phase LC and hydrophilic interaction LC, hyphenated to mass spectrometry in positive and negative ionization modes). The ANOVA multiblock OPLS (AMOPLS) method allowed us to decompose and quantify the contribution of the different experimental factors on the outcome of the TMT exposure. Results showed that the most important contribution to the overall metabolic variability came from the maturation state and treatment duration. Even though the contribution of TMT effects represented the smallest observed modulation among the three factors, it was highly statistically significant. The MetaCore™ pathway analysis tool revealed TMT-induced alterations in biosynthetic pathways and in neuronal differentiation and signaling processes, with a predominant deleterious effect on GABAergic and glutamatergic neurons. This was confirmed by combining proteomic data, increasing the confidence on the mechanistic understanding of such a toxicant exposure.

          Related collections

          Most cited references35

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          mixOmics: An R package for ‘omics feature selection and multiple data integration

          The advent of high throughput technologies has led to a wealth of publicly available ‘omics data coming from different sources, such as transcriptomics, proteomics, metabolomics. Combining such large-scale biological data sets can lead to the discovery of important biological insights, provided that relevant information can be extracted in a holistic manner. Current statistical approaches have been focusing on identifying small subsets of molecules (a ‘molecular signature’) to explain or predict biological conditions, but mainly for a single type of ‘omics. In addition, commonly used methods are univariate and consider each biological feature independently. We introduce mixOmics, an R package dedicated to the multivariate analysis of biological data sets with a specific focus on data exploration, dimension reduction and visualisation. By adopting a systems biology approach, the toolkit provides a wide range of methods that statistically integrate several data sets at once to probe relationships between heterogeneous ‘omics data sets. Our recent methods extend Projection to Latent Structure (PLS) models for discriminant analysis, for data integration across multiple ‘omics data or across independent studies, and for the identification of molecular signatures. We illustrate our latest mixOmics integrative frameworks for the multivariate analyses of ‘omics data available from the package.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment.

            Ecological risk assessors face increasing demands to assess more chemicals, with greater speed and accuracy, and to do so using fewer resources and experimental animals. New approaches in biological and computational sciences may be able to generate mechanistic information that could help in meeting these challenges. However, to use mechanistic data to support chemical assessments, there is a need for effective translation of this information into endpoints meaningful to ecological risk-effects on survival, development, and reproduction in individual organisms and, by extension, impacts on populations. Here we discuss a framework designed for this purpose, the adverse outcome pathway (AOP). An AOP is a conceptual construct that portrays existing knowledge concerning the linkage between a direct molecular initiating event and an adverse outcome at a biological level of organization relevant to risk assessment. The practical utility of AOPs for ecological risk assessment of chemicals is illustrated using five case examples. The examples demonstrate how the AOP concept can focus toxicity testing in terms of species and endpoint selection, enhance across-chemical extrapolation, and support prediction of mixture effects. The examples also show how AOPs facilitate use of molecular or biochemical endpoints (sometimes referred to as biomarkers) for forecasting chemical impacts on individuals and populations. In the concluding sections of the paper, we discuss how AOPs can help to guide research that supports chemical risk assessments and advocate for the incorporation of this approach into a broader systems biology framework.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              integrOmics: an R package to unravel relationships between two omics datasets

              Motivation: With the availability of many ‘omics’ data, such as transcriptomics, proteomics or metabolomics, the integrative or joint analysis of multiple datasets from different technology platforms is becoming crucial to unravel the relationships between different biological functional levels. However, the development of such an analysis is a major computational and technical challenge as most approaches suffer from high data dimensionality. New methodologies need to be developed and validated. Results: integrOmics efficiently performs integrative analyses of two types of ‘omics’ variables that are measured on the same samples. It includes a regularized version of canonical correlation analysis to enlighten correlations between two datasets, and a sparse version of partial least squares (PLS) regression that includes simultaneous variable selection in both datasets. The usefulness of both approaches has been demonstrated previously and successfully applied in various integrative studies. Availability: integrOmics is freely available from http://CRAN.R-project.org/ or from the web site companion (http://math.univ-toulouse.fr/biostat) that provides full documentation and tutorials. Contact: k.lecao@uq.edu.au Supplementary information: Supplementary data are available at Bioinformatics online.
                Bookmark

                Author and article information

                Journal
                Metabolites
                Metabolites
                metabolites
                Metabolites
                MDPI
                2218-1989
                24 April 2019
                April 2019
                : 9
                : 4
                : 79
                Affiliations
                [1 ]Analytical Sciences, School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, 1206 Geneva, Switzerland; victor.gonzalez@ 123456unige.ch (V.G.-R.); julian.pezzatti@ 123456unige.ch (J.P.); fabienne.jeanneret@ 123456gmail.com (F.J.); David.Tonoli@ 123456hcuge.ch (D.T.); julien.boccard@ 123456unige.ch (J.B.)
                [2 ]Swiss Centre for Applied Human Toxicology, 4055 Basel, Switzerland; domitille.schvartz@ 123456unige.ch (D.S.); jenny.sandstroem@ 123456unibas.ch (J.S.); florianne.tschudi-monnet@ 123456unil.ch (F.M.-T.); Jean-Charles.Sanchez@ 123456unige.ch (J.-C.S.)
                [3 ]Translational Biomarker Group, Department of Internal Medicine Specialties, University of Geneva, 1206 Geneva, Switzerland
                [4 ]Department of Physiology, University of Lausanne, 1005 Lausanne, Switzerland
                Author notes
                [* ]Correspondence: serge.rudaz@ 123456unige.ch ; Tel.: +41-22-379-6572
                [†]

                Current address: Clinical Research Centre, Geneva University Hospitals, 1205 Geneva, Switzerland.

                Author information
                https://orcid.org/0000-0001-7204-2363
                https://orcid.org/0000-0003-1133-0462
                https://orcid.org/0000-0002-3329-8240
                https://orcid.org/0000-0001-5913-9566
                Article
                metabolites-09-00079
                10.3390/metabo9040079
                6523777
                31022902
                281eea29-3fd1-448e-aa28-9c81cf3cfba2
                © 2019 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 19 March 2019
                : 21 April 2019
                Categories
                Article

                metabolomics,proteomics,pathway analysis,multifactorial experiments,amopls,multiplatform omics,toxicology,trimethyltin

                Comments

                Comment on this article